SubscribeLogin
pharmtech.com image

News from pharmtech.com

We’ve assigned a media bias rating of to pharmtech.com. You can read more about our methodology here.
If you want to know if pharmtech.com is credible or reliable, look no further. We rank pharmtech.com as Unknown factuality. Find out more about our methodology here.

Information about pharmtech.com

Where is pharmtech.com located?pharmtech.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Average Factuality Rating:
Learn more about Factuality Ratings.

Top pharmtech.com News

CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners - Avid Bioservices (NASDAQ:CDMO)

CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners - Avid Bioservices (NASDAQ:CDMO)

100% Center coverage: 1 sources
MONSEY, New York, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Avid Bioservices (NASDAQ:CDMO) ("Avid") to GHO Capital Partners ("GHO") and Ampersand Capital Partners ("Ampersand") for $12.50 per share in cash. The sale price is below the price target for Avid of $14.00 per share of Wall Street analyst Paul Knight of KeyBanc (source: TipRanks). If you remain an Avid …See the Story
Behind the Headlines: What the U.S. Election Results Mean for Industry, In Vivo CAR-T Applications, and more
United States · United States

Behind the Headlines: What the U.S. Election Results Mean for Industry, In Vivo CAR-T Applications, and more

Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal Trade Commission actions, tax relief, and Health and Human Services (HHS) leadership; as well as advancements in CAR-T.See the Story
MD Anderson launches cell therapy research institute
Cancer · Houston

MD Anderson launches cell therapy research institute

With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal